格隆汇1月14日|礼来公司周一表示,计划以最高25亿美元的现金收购Scorpion Therapeutics的实验性癌症疗法,以扩大其癌症治疗产品线。公司将收购Scorpion的实验性口服疗法STX-478,目前正在进行乳癌和其他晚期实体瘤的早期试验。
Clear
All
Quotes
News
Learn
Help
All
US
HK
CN
SG
AU
JP
All
News
Announcements
No matches yet
Operations too frequent. Please try again later.
Please check network settings and try again Refresh
Refresh
Loading
History record
Latest News
Quotes
More
News
More
Learn
More
Help
More
Loading
News
More
Announcements
More
Reports
More
礼来拟斥25亿美元收购癌症药物开发商Scorpion Therapeutics
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
Like
Views 391
Write a comment
Statement
This page is machine-translated. Moomoo tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.
Comment(0)
Reason For Report